XML 24 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN MEZZANINE EQUITY AND SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
At-the-market Offering
Private Placement
Common stock
Common stock
At-the-market Offering
Common stock
Private Placement
Additional paid-in capital
Additional paid-in capital
At-the-market Offering
Additional paid-in capital
Private Placement
Accumulated other comprehensive income
Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2022 3,000                    
Beginning balance at Dec. 31, 2022 $ 211                    
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Redemption of convertible preferred stock (3,000)                    
Redemption of convertible preferred stock $ (211)                    
Ending balance (in shares) at Dec. 31, 2023 0                    
Ending balance at Dec. 31, 2023 $ 0                    
Beginning balance (shares) at Dec. 31, 2022       3,229,704              
Beginning balance at Dec. 31, 2022 31,202     $ 0     $ 693,937     $ 0 $ (662,735)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Vesting of restricted stock units, net of withholding for tax and shares issued under employee share purchase plan (in shares)       50,214              
Vesting of restricted stock units, net of withholding for tax, and shares issued under employee share purchase plan (18)           (18)        
Share-based compensation 3,305           3,305        
Redemption of convertible preferred stock (149)                   (149)
Issuance of common stock, net of issuance costs (in shares)         34,589            
Issuance of common stock, net of issuance costs   $ 156           $ 156      
Issuance of common stock and pre-funded warrants, under Private Placement, net of $5,486 of issuance costs (in shares)           10,652,543          
Issuance of common stock and pre-funded warrants in Private Placement, net of $5,486 in issuance costs     $ 82,665     $ 1     $ 82,664    
Cashless exercise of pre-funded warrants (in shares)       131,838              
Unrealized gains (losses) from marketable securities 26                 26  
Net income (Loss) $ (28,452)                   (28,452)
Ending balance (shares) at Dec. 31, 2023 14,098,888     14,098,888              
Ending balance at Dec. 31, 2023 $ 88,735     $ 1     780,044     26 (691,336)
Ending balance (in shares) at Dec. 31, 2024 0                    
Ending balance at Dec. 31, 2024 $ 0                    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Vesting of restricted stock units, net of withholding for tax and shares issued under employee share purchase plan (in shares)       91,302              
Vesting of restricted stock units, net of withholding for tax, and shares issued under employee share purchase plan (112)           (112)        
Share-based compensation 3,303           3,303        
Cashless exercise of pre-funded warrants (in shares)       639,823              
Unrealized gains (losses) from marketable securities (6)                 (6)  
Net income (Loss) $ (39,834)                   (39,834)
Ending balance (shares) at Dec. 31, 2024 14,830,013     14,830,013              
Ending balance at Dec. 31, 2024 $ 52,086     $ 1     $ 783,235     $ 20 $ (731,170)